泰拉塞贝克干扰病毒性脂质生物合成蛋白表达,对其他抗生素敏感
Zhiyu Zhou1, Ruddy Wattiez2, Patricia Constant3
1Microbiology, Bioorganic & Macromolecular Chemistry Research Unit, Faculté de Pharmacie, Université libre de Bruxelles (ULB), Boulevard du Triomphe, 1050 Brussels, Belgium.
Microorganisms
|October 28, 2023
概括
一种新的抗结核药物Telacebec破坏了Mycobacterium bovis BCG.中的必需脂质毒性因子的合成. 这一发现揭示了开发结核病治疗方法的新策略,通过准菌根细菌的脂质代谢.
科学领域:
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
- 生物化学 生化学
背景情况:
- 结核病 (TB) 仍然是一个全球性卫生挑战,多种耐药菌株加剧了这一问题.
- 结核菌菌 (Mtb) 具有独特的富含脂质的细胞外,有助于其固有的抗生素耐药性和毒性.
- 泰拉塞贝克 (Q203) 是一种新型抗结核病药物,其向的是菌根细菌的电子运输链 (ETC) 细胞染色体bc1复合体.
研究的目的:
- 为了研究泰拉塞贝克对菌根菌中关键脂质毒性因子的合成的影响.
- 探索 telacebec 克服自然抗生素耐药性机制的潜力.
- 评估Telacebec与现有的抗结核药物的协同作用.
主要方法:
- 使用telacebec治疗Mycobacterium bovis BCG的方法.
- 分析与化五化酸盐 (PDIM) 和性甘油脂 (PGL) 相关的蛋白质表达.
- 评估PDIM/PGL操作子转录和与里法皮辛和万科米辛的协同作用.
- 细层染色学 (TLC) 分析细胞壁脂质.
主要成果:
- 泰拉塞贝克治疗导致参与PDIM/PGL合成的蛋白质的表达减少.
- 在Telacebec的亚抑制度下观察到PDIM/PGL合成操作子的下调.
- 泰拉塞贝克与里法皮辛和万科米辛一起表现出对BCG的协同活性.
- 在较高的Telacebec度下,没有检测到对先前存在的细胞壁PDIM的显著影响,这可能是由于生长抑制.
结论:
- 泰拉塞贝克会影响关键的真菌细菌毒性脂质的合成,这表明一种新的作用机制.
- 准脂质代谢是开发新的抗结核病策略的一个有希望的途径.
- 泰拉塞贝克与其他抗生素协同作用的能力增强了其治疗潜力.
相关概念视频
Gene Regulation in Microbial Communities: Quorum Sensing
23
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
23
Development of Antibiotic Resistance
17
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
17
Stringent Response in E. coli
17
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
17
Gram-negative Bacterial Protein Secretion Systems
30
Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...
30
Antimicrobial Effectiveness
24
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
24
Antibiotic Selection
54.5K
Overview
54.5K


